Results 201 to 210 of about 29,324 (231)
Fenofibrate prevents myocardial inflammation and fibrosis via PPARα/IκBζ signaling pathway in rat autoimmune myocarditis. [PDF]
Chang H, Wang Y, Wu Y, Shi SL, Qi Z.
europepmc +1 more source
Effect of Fenofibrate on Markers of Gut Barrier Function in Dogs With Naturally Occurring Diabetes Mellitus. [PDF]
O'Kell AL +7 more
europepmc +1 more source
LoQANT: An ImageJ Plugin for Quantifying Nuclear Staining in Immunohistochemistry and Immunofluorescence. [PDF]
Cizkova K.
europepmc +1 more source
Randomized Controlled Trial Evidence on Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. [PDF]
Dar MS +15 more
europepmc +1 more source
Efficacy and safety of statins, ezetimibe, and fibrates monotherapy or combination therapy for hyperlipidemia: a systematic review and network meta-analysis. [PDF]
Zhang S, Sun T, Song L, Jin X, Li B.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acta Crystallographica Section C Crystal Structure Communications, 2005
Unlike the related fenofibrate molecule [Henry, Zhang, Gao & Bruckner (2003). Acta Cryst. E59, o699-o700], fenofibric acid {systematic name: 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid}, C17H15ClO4, contains a carboxylic acid moiety instead of an ester moiety. This polar moiety plays an important role in the formation of a rare acid-to-ketone
Nigam P, Rath +2 more
openaire +2 more sources
Unlike the related fenofibrate molecule [Henry, Zhang, Gao & Bruckner (2003). Acta Cryst. E59, o699-o700], fenofibric acid {systematic name: 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid}, C17H15ClO4, contains a carboxylic acid moiety instead of an ester moiety. This polar moiety plays an important role in the formation of a rare acid-to-ketone
Nigam P, Rath +2 more
openaire +2 more sources

